Navigation Links
BioSpecifics Technologies Corp. Announces FDA Approval of XIAFLEX(TM) for Treatment of Dupuytren's Contracture
Date:2/2/2010

es Corp.

BioSpecifics Technologies Corp. is a biopharmaceutical company that has developed injectable collagenase for eleven clinical indications, three of which include: Dupuytren's contracture, Peyronie's disease, and frozen shoulder (adhesive capsulitis). Its strategic partner Auxilium has announced the approval of XIAFLEX for the treatment of Dupuytren's contracture. Pfizer, Inc. is responsible for marketing XIAFLEX in Europe.

Forward Looking Statements

This press release includes forward-looking statements within the meaning of the Private

Securities Litigation Reform Act of 1995. Any statements, other than statements of historical fact, including statements regarding the company's strategy, future operations, future financial position, future revenues, projected costs, prospects, plans and objectives of management, its expected revenue growth, and any other statements containing the words "believes", "expects", "anticipates", "plans", "estimates" and similar expressions, are forward-looking statements. There are a number of important factors that could cause its actual results to differ materially from those indicated by such forward-looking statements, including the ability of its partner Auxilium to achieve a successful launch of XIAFLEX for Dupuytren's in the United States, obtain regulatory approval of XIAFLEX™ in the United States for Peyronie's disease and the ability of Pfizer to obtain regulatory approval of XIAFLEX™ in its territory for Dupuytren's contracture and Peyronie's disease, which will determine the amount of milestone, royalty and sublicense income payments it may receive; the amount of earn out payments it may receive from DFB Biotech Inc. and its affiliates; whether Auxilium exercises its option under the companies' license agreement for additional indications; the po
'/>"/>

SOURCE BioSpecifics Technologies Corp.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. BioSpecifics Technologies Corp. Announces Initiation of Phase IIb Trial for Peyronies Disease
2. BioSpecifics Technologies Corp. to Present at Cowen and Company 29th Annual Health Care Conference
3. BioSpecifics Technologies Corp. Announces XIAFLEX(TM) CORD I Study Published in New England Journal of Medicine
4. BioSpecifics Technologies Corp. to Present at the Piper Jaffray 21st Annual Health Care Conference
5. BioSpecifics Technologies Corp. Announces Top-Line Phase 2b Results for XIAFLEX(TM) for Treatment of Peyronies Disease
6. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
7. King Pharmaceuticals and Palatin Technologies Delay Immediate Plans for Phase 3 Clinical Program With Bremelanotide for Erectile Dysfunction
8. Rockwell Medical Technologies, Inc. Begins Patient Enrollment for its SFP Dose-Ranging Study
9. Rockwell Medical Technologies, Inc. Begins Dosing Patients for SFP Phase IIb Clinical Study
10. New Clinical Studies Confirm Mauna Kea Technologies Cellvizio(R) GI in Range of Procedures
11. Palatin Technologies, Inc. Reports Initiation of Human Trials for the Treatment of Congestive Heart Failure
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/5/2015)... GAITHERSBURG, Md. , Aug. 5, 2015 /PRNewswire/ ... an oncology company focusing on genetic and epigenetic ... research and development arm of AstraZeneca, today announced ... collaboration ("Collaboration Agreement"). The Phase I/II study will ... spectrum-selective histone deacetylase (HDAC) inhibitor, mocetinostat, in combination ...
(Date:8/5/2015)... Mordor Intelligence releases their report ... segmented by Packaging Type for Ampoules (Glass, Plastic) - ... Geographical Region ( North America , ... & Africa ) - ... Analysis (2015-2020).      (Logo: http://photos.prnewswire.com/prnh/20150428/740799 ) ...
(Date:8/4/2015)... , Aug. 4, 2015 Young ... supplies and equipment, today announced the acquisition of ... Products Laboratories, Inc. ("MPL PDCMD"). MPL PDCMD manufactures ... in preventive and restorative dental procedures. ... of our business in attractive, high-growth segments," said ...
Breaking Medicine Technology:Mirati Therapeutics And MedImmune Partner On Immuno-Oncology Combination In Lung Cancer 2Mirati Therapeutics And MedImmune Partner On Immuno-Oncology Combination In Lung Cancer 3Mirati Therapeutics And MedImmune Partner On Immuno-Oncology Combination In Lung Cancer 4Mirati Therapeutics And MedImmune Partner On Immuno-Oncology Combination In Lung Cancer 5Mirati Therapeutics And MedImmune Partner On Immuno-Oncology Combination In Lung Cancer 6DuPont, Mitsubishi Chemical Holdings and Amcor Among Other Organizations are Expected to Invest in the Asia-Pacific and Latin American Ampoules Packaging Market 2DuPont, Mitsubishi Chemical Holdings and Amcor Among Other Organizations are Expected to Invest in the Asia-Pacific and Latin American Ampoules Packaging Market 3Young Innovations Announces Acquisition of Medical Products Laboratories' Professional Dental Contract Manufacturing Division 2
... 19, 2011 Innovation, makers of PharmASSIST® pharmacy automation ... pharmacy automation product, PharmASSIST OPTIx™, at Cardinal Health,s Retail ... 21-23 and at the NACDS Pharmacy & Technology Conference ... an optical counting and imaging technology that enables pharmacies ...
... /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: ... R&D outsourcing company with operations in China and the ... results for the second quarter of 2011 after the ... 2011 (which will be Thursday morning, August 11, 2011 ...
Cached Medicine Technology:Innovation to Unveil New Pharmacy Automation Product at Key Pharmacy Industry Trade Shows 2WuXi PharmaTech Schedules Second-Quarter 2011 Earnings Release 2
(Date:8/5/2015)... ... August 05, 2015 , ... Stelari introduces their new ... yoga wear with their new line, The Earth’s Song. Combining fashion and activewear, Stelari’s ... your workout. Inspired by the Australian Outback, this collection is sure to make the ...
(Date:8/5/2015)... Saint-Malo, FR (PRWEB) , ... August 05, 2015 , ... ... a versatile new serum formulated with a quartet of beauty-enhancing marine and plant oils. ... it features rose oil which stands out for its lovely scent and soothing ...
(Date:8/5/2015)... ... ... Over 6,500 athletes from 177 nations recently descended upon the Los Angeles metropolitan ... 2015 (July 25 to August 2). , Officially opened by First Lady Michelle Obama, ... 1984 Olympics, and the Los Angeles Coliseum was once again filled up with thousands ...
(Date:8/4/2015)... ... August 05, 2015 , ... In reaction to a ... liquid propane gas (LPG) next to Seneca Lake*, the full Executive Committee of ... resolution that strongly opposes that permit. *, ** , “1199SEIU healthcare workers have ...
(Date:8/4/2015)... ... August 05, 2015 , ... The National ... 2015-2016 inductee into its VIP Woman of the Year Circle. She is recognized ... networking organization exclusively for professional women, boasting more than 700,000 members and over ...
Breaking Medicine News(10 mins):Health News:Stelari: Bohemian Chic Activewear Line 2Health News:Stelari: Bohemian Chic Activewear Line 3Health News:Phytomer launches ROSÉE SOIN Radiance Replenishing Oil 2Health News:Phytomer launches ROSÉE SOIN Radiance Replenishing Oil 3Health News:Phytomer launches ROSÉE SOIN Radiance Replenishing Oil 4Health News:CPMA Member Podiatrists Ensure Fit Feet at the Special Olympics World Games in Los Angeles 2Health News:CPMA Member Podiatrists Ensure Fit Feet at the Special Olympics World Games in Los Angeles 3Health News:Opposition Mounting to Permit Liquid Propane Gas Storage Next to New York’s Seneca Lake 2Health News:Opposition Mounting to Permit Liquid Propane Gas Storage Next to New York’s Seneca Lake 3Health News:NAPW Inducts Deborah Stevens, Executive Assistant to Chairman and CEO at Mirion Technologies, Inc., Into its VIP Woman of the Year Circle 2
... ATS Medical, Inc.,(Nasdaq: ATSI ), manufacturer ... services, today noted that several key opinion ... Medical products and related,procedures during the scientific ... Invasive Cardiothoracic Surgery (ISMICS) annual,meeting in Boston., ...
... 9 /PRNewswire-FirstCall/ - QLT Inc. (NASDAQ: QLTI; TSX:,QLT) ... subsidiary, has,entered into an asset purchase agreement with ... (NYSE: AGN ) to fully divest QLT,s,worldwide ... in,the United States and Canada for the treatment ...
... to Effectively Adapt to Change is Key Focus ... for ... provider of business,process outsourcing solutions for health payers, today announced that ... Insurance,Plans (AHIP) annual meeting. The Friday, June 20 breakfast meeting session,will ...
... WESTCHESTER, Ill. A significant number of women worrying ... a breast cancer diagnosis, according to a research abstract ... Monday at SLEEP 2008, the 22nd Annual Meeting of ... study, from the Brooklyn Health Disparities Center at SUNY ...
... may lower the risk of sleep problems in Caucasian women, ... research abstract that will be presented on Monday at SLEEP ... Societies (APSS). , The study, authored by Wendy M. Troxel, ... women from the Study of Womens Health Across the Nation, ...
... abstract that will be presented on Monday at SLEEP ... Sleep Societies (APSS), identifies a number of personal health, ... for a restorative nap during the night shift among ... and work environment for achieving naps. A strategy ...
Cached Medicine News:Health News:ATS Medical Products Prominently Featured in International Society for Minimally Invasive Cardiothoracic Surgery (ISMICS) Scientific Presentations 2Health News:ATS Medical Products Prominently Featured in International Society for Minimally Invasive Cardiothoracic Surgery (ISMICS) Scientific Presentations 3Health News:QLT announces agreement to sell Aczone(R) to Allergan for approximately US$150 million 2Health News:QLT announces agreement to sell Aczone(R) to Allergan for approximately US$150 million 3Health News:QLT announces agreement to sell Aczone(R) to Allergan for approximately US$150 million 4Health News:QLT announces agreement to sell Aczone(R) to Allergan for approximately US$150 million 5Health News:Adaptis Seminar to Provide Strategies for Managing Market Transformations 2Health News:Women worrying about cancer are more likely to experience sleep disturbances 2Health News:More marital happiness = less sleep complaints 2Health News:Nurses working overnight support the need for a restorative nap during the night shift 2
... the pioneers of surgical lighting, including ... automatic reserve bulb, an integrated surgical ... sets the standard for advanced lighting ... our latest generation surgical light ...
... SimpliCT® is an interventional guidance device ... significantly improve the accuracy of computed ... to improving accuracy, SimpliCT® also has ... of CT-guided puncture procedures including biopsies ...
Flat tip, bare fiber, no cooling, polished SMA 905, 3 meters long. Sold in boxes of five. Each part is individually packaged in sterile Tyvek bags....
Get YAG laser performance from your diode laser. Our proprietary NA shift technology offers efficient coupling of low divergence fiber to high divergence lasers...
Medicine Products: